|
|
||||||||



Departments of
*
Pathology and
Microbiology, University of Virginia, Charlottesville, VA 22908
Female (C57BL/6xA/J)F1 mice undergoing thymectomy on
day 3 after birth (d3tx) developed autoimmune ovarian disease
(AOD) and autoimmune disease of the lacrimal gland. As both were
prevented by normal adult CD25+ T cells, regulatory T cell
depletion is responsible for d3tx diseases. AOD began as oophoritis at
3 wk. By 4 wk, AOD progressed to ovarian atrophy with autoantibody
response against multiple oocyte Ag of early ontogeny. The requirement
for immunogenic endogenous ovarian Ag was investigated in d3tx female
mice, d3tx male mice, and d3tx neonatally ovariectomized (OX) females.
At 8 wk, all mice had comparable lacrimalitis but only those with
endogenous ovaries developed AOD in ovarian grafts. The duration of Ag
exposure required to initiate AOD was evaluated in d3tx mice OX at 2,
3, or 4 wk and engrafted with an ovary at 4, 5, or 6 wk,
respectively. The mice OX at 2 wk did not have oophoritis whereas
80% of mice OX at 3 or 4 wk had maximal AOD, thus Ag stimulus for
2.5 wk following d3tx is sufficient. AOD progression requires
additional endogenous Ag stimulation from the ovarian graft. In mice OX
at 3 wk, ovaries engrafted at 5 wk had more severe oophoritis than
ovaries engrafted at 6 or 12 wk; moreover, only mice engrafted at 5 wk
developed ovarian atrophy and oocyte autoantibodies. Similar results
were obtained in mice OX at 4 wk. Thus endogenous tissue Ag are
critical in autoimmune disease induction and progression that occur
spontaneously upon regulatory T cell depletion.
This article has been cited by other articles:
![]() |
L. R. Guerin, J. R. Prins, and S. A. Robertson Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update, March 11, 2009; (2009) dmp004v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Samy, K. M. Wheeler, R. J. Roper, C. Teuscher, and K. S. K. Tung Cutting Edge: Autoimmune Disease in Day 3 Thymectomized Mice Is Actively Controlled by Endogenous Disease-Specific Regulatory T Cells J. Immunol., April 1, 2008; 180(7): 4366 - 4370. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Alard, J. N. Manirarora, S. A. Parnell, J. L. Hudkins, S. L. Clark, and M. M. Kosiewicz Deficiency in NOD Antigen-Presenting Cell Function May Be Responsible for Suboptimal CD4+CD25+ T-Cell-Mediated Regulation and Type 1 Diabetes Development in NOD Mice. Diabetes, July 1, 2006; 55(7): 2098 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yu, P. K. Maiti, M. Dyson, R. Jain, and H. Braley-Mullen B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis J. Exp. Med., February 21, 2006; 203(2): 349 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Setiady, K. Ohno, E. T. Samy, H. Bagavant, H. Qiao, C. Sharp, J. X. She, and K. S. K. Tung Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+CD25+ regulatory T cells Blood, February 1, 2006; 107(3): 1056 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wolf, A. M. Wolf, H. Rumpold, H. Fiegl, A. G. Zeimet, E. Muller-Holzner, M. Deibl, G. Gastl, E. Gunsilius, and C. Marth The Expression of the Regulatory T Cell-Specific Forkhead Box Transcription Factor FoxP3 Is Associated with Poor Prognosis in Ovarian Cancer Clin. Cancer Res., December 1, 2005; 11(23): 8326 - 8331. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Samy, L. A. Parker, C. P. Sharp, and K. S.K. Tung Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node J. Exp. Med., September 19, 2005; 202(6): 771 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Shih, L. Mandik-Nayak, B. T. Wipke, and P. M. Allen Massive Thymic Deletion Results in Systemic Autoimmunity through Elimination of CD4+ CD25+ T Regulatory Cells J. Exp. Med., February 2, 2004; 199(3): 323 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Setiady, E. T. Samy, and K. S. K. Tung Maternal Autoantibody Triggers De Novo T Cell-Mediated Neonatal Autoimmune Disease J. Immunol., May 1, 2003; 170(9): 4656 - 4664. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sharp, C. Thompson, E. T. Samy, R. Noelle, and K. S. K. Tung CD40 Ligand in Pathogenesis of Autoimmune Ovarian Disease of Day 3-Thymectomized Mice: Implication for CD40 Ligand Antibody Therapy J. Immunol., February 15, 2003; 170(4): 1667 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bagavant, C. Thompson, K. Ohno, Y. Setiady, and K. S. K. Tung Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease Int. Immunol., December 1, 2002; 14(12): 1397 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roper, R. Z. Ma, J. E. Biggins, R. J. Butterfield, S. D. Michael, K. S. K. Tung, R. W. Doerge, and C. Teuscher Interacting Quantitative Trait Loci Control Loss of Peripheral Tolerance and Susceptibility to Autoimmune Ovarian Dysgenesis After Day 3 Thymectomy in Mice J. Immunol., August 1, 2002; 169(3): 1640 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hori, M. Haury, A. Coutinho, and J. Demengeot Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice PNAS, June 11, 2002; 99(12): 8213 - 8218. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-B. Tong, C. A. Bondy, J. Zhou, and L. M. Nelson A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development Hum. Reprod., April 1, 2002; 17(4): 903 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bagavant, C. Sharp, B. Kurth, and K. S. K. Tung Induction and Immunohistology of Autoimmune Ovarian Disease in Cynomolgus Macaques (Macaca fascicularis) Am. J. Pathol., January 1, 2002; 160(1): 141 - 149. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |